Question:
This Compound 2,5,8,11,14,17,20,23,26-nona-oxaoctacosan-28-yl p-(butylamino) benzoate is usually known for its activity?
This Compound 2,5,8,11,14,17,20,23,26-nona-oxaoctacosan-28-yl p-(butylamino) benzoate is usually known for its activity?
Updated On: Jul 23, 2024
- Antifungal
- Antitussive
- Vitamin
- Glucocorticoid
Hide Solution
Verified By Collegedunia
The Correct Option is B
Solution and Explanation
The correct option is (B): Antitussive
Was this answer helpful?
0
0
Top Questions on Amino Acids
- Consider the following statements:
Statement-I: Lysine, arginine are essential and basic amino acids.
Statement-II: Leucine, phenyl alanine are non-essential and neutral amino acids.
Which of the following is correct?- AP EAPCET - 2025
- Chemistry
- Amino Acids
- Consider the two \( pK_a \) values of valine as 2.32 and 9.62. The isoelectric point (pI) of this amino acid is ....... (rounded off to two decimal places)
- GATE XL - 2025
- Chemistry
- Amino Acids
- Identify the correct statement among the following:
- JEE Main - 2025
- Chemistry
- Amino Acids
- Which of the following compounds is least likely to give effervescence of CO$_2$ in presence of aq. NaHCO$_3$?
- JEE Main - 2025
- Chemistry
- Amino Acids
A dipeptide, “x”, on complete hydrolysis gives “y” and “z”; “y” on treatment with aqueous HNO$_2$, produces lactic acid. On the other hand, “z” on heating gives the following cyclic molecule.
Based on the information given, the dipeptide X is:- JEE Main - 2025
- Chemistry
- Amino Acids
View More Questions
Questions Asked in GPAT exam
- If the label or the container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist, it is:
- GPAT - 2025
- Drug therapy
- Match the following:
(P) Schedule H
(Q) Schedule G
(R) Schedule P
(S) Schedule F2
Descriptions:
(I) Life period of drugs
(II) Drugs used under RMP
(III) List of Prescription Drugs
(IV) Standards for surgical dressing- GPAT - 2025
- Drug therapy
- Match the following:
(1) Schedule FF
(2) Schedule F3
(3) Schedule V
(4) Schedule Y
Descriptions:
(P) Standards of patent and proprietary medicines
(Q) Requirements and guidelines for clinical trials
(R) Standards for sterilized umbilical tapes
(S) Standards for Ophthalmic preparations- GPAT - 2025
- Drug therapy
Match the following Class and their Drug:
(1) Alkylating (P) 5-fluorouracil
(2) Platinum analog (Q) Cisplatin
(3) Antimetabolite (R) Cetuximab
(4) EGF receptor inhibitor (S) Chlorambucil- GPAT - 2025
- Biostatistics and Research Methodology
- Common name of convective transport
- GPAT - 2025
- Pharmaceutical Analysis
View More Questions